Tesla's quarterly deliveries beat analysts' estimates

Tesla reported record third-quarter deliveries of 497,099 vehicles, significantly surpassing analyst estimates, primarily driven by a rush in U.S. demand ahead of the federal tax credit expiry, which offset a 22.5% decline in European sales. Despite this strong performance, analysts anticipate a sales slump in Q4 and project 2025 deliveries to be 10% lower than 2024, suggesting the Q3 boost was a pull-forward rather than sustained growth. Shares rose 3.1% premarket, while a proposed new CEO award for Elon Musk, potentially valued at up to $1 trillion, awaits shareholder approval.

Analysis

Tesla reported record third-quarter deliveries of 497,099 vehicles, a 7.4% year-over-year increase that significantly surpassed analyst estimates of approximately 443,919. This performance, which prompted a 3.1% premarket share price increase, was primarily driven by a pull-forward of demand in the United States as customers rushed to capitalize on a $7,500 federal tax credit before its September 30 expiration. However, this U.S. strength masked considerable weakness in Europe, where sales fell 22.5% from the prior year, cutting Tesla's market share to 1.5% amid rising competition from plug-in hybrids and Chinese brands. The temporary nature of the Q3 beat is a key concern, with analysts anticipating a sales slump in the fourth quarter. Furthermore, Visible Alpha's projection for full-year 2025 deliveries to be around 1.61 million, approximately 10% below 2024 levels, signals a potential deceleration in growth that challenges the company's long-term trajectory. While initiatives like the Model Y L launch in China aim to spur demand, and a robotaxi pilot is underway, the most significant non-operational item is a proposed new CEO award for Elon Musk, which carries major governance implications for shareholders.

Key Decisions for Investors

• Investors should view the record Q3 delivery figure with caution, as it was heavily influenced by a temporary U.S. tax credit expiration and analysts forecast a subsequent sales slump in Q4.
• The 22.5% sales decline and market share loss in Europe highlights significant competitive headwinds, making it critical to monitor the company's performance against rivals in key international markets.
• Analyst projections for a 10% delivery decline in 2025 versus 2024 directly challenge the high-growth narrative supporting the stock's valuation, warranting a re-evaluation of long-term financial models.
• The proposed CEO compensation plan represents a major governance event that requires careful consideration of its potential impact on shareholder dilution and alignment with long-term value.